Keyphrases
Economic Evaluation
100%
Motor Neuron Disease
100%
Economic Study
100%
Systematic Methodological Review
100%
Cost Study
50%
Utility Study
50%
Evaluation Database
50%
Mutually Exclusive
25%
Cost Estimation
25%
Large Cohort
25%
Riluzole
25%
Standard Gamble
25%
Specific Cost
25%
High Variability
25%
Lack of Data
25%
Caregivers
25%
Patient Well-being
25%
Expert Opinion
25%
Uncertain Data
25%
Disease Stage
25%
Health Impact
25%
Indirect Costs
25%
Location-specific
25%
Methodological Issues
25%
Embase
25%
Modeling Framework
25%
MEDLINE
25%
Health Status
25%
EQ-5D
25%
Evaluation Costs
25%
Methodological Aspects
25%
EQ-5D Questionnaire
25%
Disease Course
25%
Motor Function
25%
Markov
25%
Cost-utility
25%
Health Economic Evaluation
25%
Health Technology Assessment
25%
Life Expectancy
25%
Agricultural and Biological Sciences
Quality of Life
100%
Riluzole
100%
Caregiver
100%
Motor Neuron
100%
Expert Opinion
100%
Pharmacology, Toxicology and Pharmaceutical Science
Disease
100%
Motor Neuron Disease
100%
Health Status
50%
Life Expectancy
50%
Disease Course
50%
Riluzole
50%
Computer Science
Methodological Issue
100%
Motor Function
100%
Expert Opinion
100%
Modeling Framework
100%
Economics, Econometrics and Finance
Indirect Costs
100%
Health Economics
100%
Methodological Critique
100%
Life Cycle
100%